InoLife Technologies Introduces the Marketing of JuVesse as the First of Its Skin Care Line of Products Global Market for Skin Care Products Remains Robust, With North American and EU Sales Projected to Reach $274 Billion by 2013 RALEIGH, N.C., Jan. 31, 2013 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. ("InoLife") (OTCQB:INOLD), announces they will begin marketing the JuVesse skin care product as the first of many new and exciting skin care products. JuVesse is an age reversing product which is a chemical free formula for the activation of endogenous "stem cells" in the skin and body, formulated exclusively from all natural ingredients. The underlying science and technology embodied in these products was the result of over two decades of international and domestic research into the natural causes of aging, and how to reverse the aging process. This breakthrough science has multiple applications including creams and lotions for "anti-aging" or "age reverses" stimulating follicle growth, facilitating skin repair and curing cystic acne.The JuVesse cream for the face and body contain "anti-aging benefits" by activating the body's own "stem cells" in the skin to increase the natural substances which promote moisture and fullness in the skin, and activate each cell to regenerate the tissue.This technology is actually using nature itself to reverse its own natural aging processes. "We feel the timing is great for the introduction of the JuVesse skin care product.This is the first of many other exciting new skin care products.The global market for skin care products remains robust, with North American and EU sales projected to reach $274 Billion by 2013," said Gary Berthold, CEO of InoLife."The "anti aging" segment of the skin care is burgeoning. This explosive growth is being bolstered by the aging baby boomer population and the increasing awareness about age prevention by younger consumers in the 25 to 30 year old age group." About InoLife Technologies, Inc. InoLife Technologies' mission is to aggressively identify, manufacture and market innovative and affordable healthcare products and services directly to the marketplace. InoLife Technologies, Inc. markets the commercial use of proprietary Intellectual Property by manufacturing, brand marketing and selling an integrated program of age reversing creams and lotions. "Safe Harbor Statement" InoLife Technologies, Inc. (OTCQB:INOLD), believes it is well prepared to succeed in both its geographic and strategic focus areas based on the new ideas and extensive experience of its management team. One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. InoLife Technologies, Inc. (OTCQB:INOLD), urges investors to review the risks and uncertainties contained within its filings with the Securities and Exchange Commission. For further company information, please visit http://www.inol.info. CONTACT: InoLife Technologies, Inc Investor Relations: William A. Young Sr. Ph: 623-238-5245 E-mail: firstname.lastname@example.org
InoLife Technologies Introduces the Marketing of JuVesse as the First of Its Skin Care Line of Products
Press spacebar to pause and continue. Press esc to stop.